
InfuSystems rose 51.4% from $10.09 to a 1-year high of $15.28, ahead of the S&P 500's +10.0%. Its worst day was May 7 (−11.5%), and its low came Feb 12 at $7.42.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
InfuSystems closed at its lowest level of the year, 26.5% below where the year started.
−2.5% · S&P 500 −1.5%
EPS of $0.10 beat the $0.07 estimate on $36.2M revenue (est. $36.6M).
Story events cover the past 12 months · Times ET
+13.5% · S&P 500 +0.7%
EPS of $0.05 beat the $0.04 estimate on $33.7M revenue (est. $34.4M).
−11.5%, the year's worst day · S&P 500 −0.3%
InfuSystems shares rose 11.0%, while the S&P 500 fell 0.7%.
+11.0%, on 3M shares, the year's heaviest volume · S&P 500 −0.7%
EPS of $0.15 beat the $0.11 estimate on $36.9M revenue (est. $36.4M).
+33.6%, the year's best day · S&P 500 +1.8%
EPS of $0.15 beat the $0.12 estimate on $37.6M revenue (est. $37.3M).
+3.1% · S&P 500 −4.4%
Where it ended: a 1-year high close of $15.28 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.13, revenue est. $37.3M).
Nothing in the past 12 months.
All INFU dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INFU and SPY from Benzinga historical bars. Not investment advice.